ADVERTISEMENTREMOVE AD
Members Only
lock close icon

FAQ | DCGI Approves India's First Indigenous mRNA COVID Vaccine - What To Know

Gennova Pharmaceuticals and AIC-CCMB are leading the charge in mRNA vaccines against COVID-19 in India.

Updated: 
story-hero-img
i
Aa
Aa
Small
Aa
Medium
Aa
Large

The Drugs Controller General of India (DCGI) approved the emergency use of India's first mRNA COVID vaccine for those 18 years and above, on Tuesday, 28 June.

The mRNA vaccine, called Gemcovac-19, is being developed by Gennova Biopharmaceuticals in Pune.

The vaccine is expected to be available in the private market by July 2022.

Apart from this, The Council of Scientific and Industrial Research (CSIR), the Atal Incubation Centre and the Centre for Cellular and Molecular Biology (CCMB) had in May 2022 also pitched an mRNA vaccine, pegged as India's first ever indigenous mRNA vaccine to fight SARS-CoV-2 and COVID-19.

Here's everything you need to know about India's mRNA COVID-19 vaccines.

Published: 
Become a Member to unlock
  • Access to all paywalled content on site
  • Ad-free experience across The Quint
  • Listen to paywalled content
  • Early previews of our Special Projects
×
×